| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 2644 |
| 1 | LANSOPRAZOLE | 1993 |
| 2 | ESOMEPRAZOLE MAGNESIUM | 1898 |
| 3 | ESOMEPRAZOLE SODIUM | 1702 |
| 4 | PANTOPRAZOLE SODIUM | 1076 |
| 5 | DEXLANSOPRAZOLE | 742 |
| 6 | OMEPRAZOLE | 322 |
| 7 | EXENATIDE | 128 |
| 8 | PANTOPRAZOLE | 128 |
| 9 | ASPIRIN | 110 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ARSENICUM ALBUM, EUPHORBIUM OFFICINARUM, HEPAR SULPHURIS CALCAREUM, HISTAMINUM, IODIUM, LYCOPODIUM, PULSATILLA | 1 | 0.0303 |
| 1 | INHALANT | 1 | 0.0208 |
| 2 | DEXLANSOPRAZOLE | 742 | 0.0204 |
| 3 | NERATINIB | 26 | 0.0137 |
| 4 | LANSOPRAZOLE | 1993 | 0.0135 |
| 5 | ESOMEPRAZOLE SODIUM | 1702 | 0.0102 |
| 6 | PANTOPRAZOLE SODIUM | 1076 | 0.0096 |
| 7 | ESOMEPRAZOLE MAGNESIUM | 1898 | 0.0092 |
| 8 | OMEPRAZOLE AND SODIUM BICARBONATE | 21 | 0.0073 |
| 9 | OMEPRAZOLE MAGNESIUM | 2644 | 0.0072 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 2178 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 281 |
| 2 | GLP-1 Receptor Agonist [EPC] | 239 |
| 3 | Corticosteroid [EPC] | 161 |
| 4 | Benzodiazepine [EPC] | 154 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 122 |
| 6 | Histamine-2 Receptor Antagonist [EPC] | 113 |
| 7 | Insulin Analog [EPC] | 103 |
| 8 | Provitamin D2 Compound [EPC] | 100 |
| 9 | Kinase Inhibitor [EPC] | 89 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 2178 | 0.0048 |
| 1 | RNA Synthetase Inhibitor Antibacterial [EPC] | 17 | 0.0020 |
| 2 | Bismuth [EPC] | 7 | 0.0016 |
| 3 | Methylating Agent [EPC] | 1 | 0.0013 |
| 4 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0012 |
| 5 | GLP-1 Receptor Agonist [EPC] | 239 | 0.0012 |
| 6 | Aluminum Complex [EPC] | 17 | 0.0009 |
| 7 | Carnitine Analog [EPC] | 2 | 0.0009 |
| 8 | Plasma Volume Expander [EPC] | 2 | 0.0009 |
| 9 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0008 |